Document Detail


Thrombolytic therapy in vertebrobasilar occlusion.
MedLine Citation:
PMID:  1343857     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since 1983 at the Alfred Hospital 4 patients with thrombotic or embolic vertebrobasilar occlusions have been treated with intra-arterial streptokinase (SK) infusions for the effects of persisting brainstem ischaemia despite anticoagulation with heparin. In 3 cases there was immediate and dramatic neurological improvement, in all cases associated with arteriographically demonstrated reperfusion of a blocked vessel. Two of these patients suffered further thromboembolic vertebral or basilar artery occlusions (3 days and 2 years later) but recovered fully without further thrombolytic therapy. The other patient was given intra-arterial SK 12 days after an apparently completed brainstem stroke: the therapy failed to cause reperfusion of a vertebral occlusion or produce any clinical improvement. Complications from the therapy were nausea requiring the termination of the SK infusion in one case, easily controlled bleeding from a recent surgical wound, and a clinically insignificant haemorrhagic transformation of cerebellar infarction in a third. The benefits of thrombolytic therapy in vertebrobasilar ischaemia and the dose of streptokinase required are discussed.
Authors:
D Thyagarajan; R J Stark; J Frayne; B S Gilligan; N Sacharias
Related Documents :
1986507 - Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates a...
3154687 - What is established in thrombolytic therapy of acute myocardial infarction? pharmacolog...
1825097 - A randomized placebo-controlled trial of combined early intravenous captopril and recom...
9489987 - Resource use and quality of care for medicare patients with acute myocardial infarction...
24791727 - A new technique for coronary guide catheter exchange over coronary guidewire using guid...
15148267 - Electrical and mechanical components of dyssynchrony in heart failure patients with nor...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Clinical and experimental neurology     Volume:  29     ISSN:  0196-6383     ISO Abbreviation:  Clin Exp Neurol     Publication Date:  1992  
Date Detail:
Created Date:  1994-03-31     Completed Date:  1994-03-31     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7909724     Medline TA:  Clin Exp Neurol     Country:  AUSTRALIA    
Other Details:
Languages:  eng     Pagination:  129-42     Citation Subset:  IM    
Affiliation:
Department of Neurology, Alfred Hospital, Melbourne.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cerebral Angiography
Female
Humans
Injections, Intra-Arterial
Male
Middle Aged
Streptokinase / therapeutic use
Thrombolytic Therapy* / adverse effects
Tomography, X-Ray Computed
Vertebrobasilar Insufficiency / radiography,  therapy*
Chemical
Reg. No./Substance:
EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predicting survival after stroke: experience from the Perth Community Stroke Study.
Next Document:  Confounding factors in non-invasive tests of neurovascular function in diabetes mellitus.